Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mai Yamada

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Public Health Nutrition|January 20, 2010
Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populationsMai Yamada, Satoshi Sasaki, Kentaro Murakami, et al.
International Journal of Clinical Oncology|June 18, 2011
High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancersAkiyo Horio, Takashi Fujita, Hironori Hayashi, et al.
Clinical Breast Cancer|December 4, 2021
Current Status and Problems of Breast Cancer Treatment with SchizophreniaKazuhisa Kaneshiro, Makoto Kubo, Masahiko Taniguchi, et al.
Surgical Case Reports|March 22, 2024
Beckwith-Wiedemann syndrome with juvenile fibrous nodules and lobular breast tumors: a case report and review of the literatureYo Sato, Yusuke Watanabe, Takafumi Morisaki, et al.
Anticancer Research|July 27, 2022
Significance of the Multi-gene Panel myRisk in JapanSaori Hayashi, Makoto Kubo, Sawako Matsuzaki, et al.
Breast Cancer (Tokyo, Japan)|October 2, 2025
Characterization of gut microbiota dysbiosis in breast cancer patientsMai Yamada, Makoto Kubo, Kazuhisa Kaneshiro, et al.
Cancers|March 28, 2024
<i>TP53</i> and/or <i>BRCA1</i> Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast CancerAkiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, et al.
Surgical Case Reports|October 11, 2022
A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndromeMasaya Kai, Makoto Kubo, Sawako Shikada, et al.
Breast Cancer (Tokyo, Japan)|January 8, 2020
Microsatellite instability in Japanese female patients with triple-negative breast cancerKanako Kurata, Makoto Kubo, Masaya Kai, et al.
Anticancer Research|July 20, 2021
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast CancerMai Yamada, Makoto Kubo, Hidetaka Yamamoto, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Public Health Nutrition|January 20, 2010
Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populationsMai Yamada, Satoshi Sasaki, Kentaro Murakami, et al.
International Journal of Clinical Oncology|June 18, 2011
High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancersAkiyo Horio, Takashi Fujita, Hironori Hayashi, et al.
Clinical Breast Cancer|December 4, 2021
Current Status and Problems of Breast Cancer Treatment with SchizophreniaKazuhisa Kaneshiro, Makoto Kubo, Masahiko Taniguchi, et al.
Surgical Case Reports|March 22, 2024
Beckwith-Wiedemann syndrome with juvenile fibrous nodules and lobular breast tumors: a case report and review of the literatureYo Sato, Yusuke Watanabe, Takafumi Morisaki, et al.
Anticancer Research|July 27, 2022
Significance of the Multi-gene Panel myRisk in JapanSaori Hayashi, Makoto Kubo, Sawako Matsuzaki, et al.
Breast Cancer (Tokyo, Japan)|October 2, 2025
Characterization of gut microbiota dysbiosis in breast cancer patientsMai Yamada, Makoto Kubo, Kazuhisa Kaneshiro, et al.
Cancers|March 28, 2024
<i>TP53</i> and/or <i>BRCA1</i> Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast CancerAkiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, et al.
Surgical Case Reports|October 11, 2022
A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndromeMasaya Kai, Makoto Kubo, Sawako Shikada, et al.
Breast Cancer (Tokyo, Japan)|January 8, 2020
Microsatellite instability in Japanese female patients with triple-negative breast cancerKanako Kurata, Makoto Kubo, Masaya Kai, et al.
Anticancer Research|July 20, 2021
Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast CancerMai Yamada, Makoto Kubo, Hidetaka Yamamoto, et al.
Pageof 5